Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Stadlbauer, V; Tauss, J; Portugaller, HR; Stiegler, P; Iberer, F; Stauber, RE.
Hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): management with L-ornithine-L-aspartate and stent reduction.
Metab Brain Dis. 2007; 22(1): 45-50.
Doi: 10.1007/s11011-006-9032-3
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Führende Autor*innen der Med Uni Graz
- Stadlbauer-Köllner Vanessa
- Co-Autor*innen der Med Uni Graz
- Iberer Florian
- Portugaller Rupert
- Stauber Rudolf
- Stiegler Philipp
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Hepatic encephalopathy (HE) is a common problem after insertion of a trans-jugular intrahepatic portosystemic shunt (TIPS), which may be difficult to manage. We present a case of severe post-TIPS HE unresponsive to high doses of L-ornithine-L-aspartate (LOLA) despite reduction of venous ammonia levels in a dose-dependent fashion. Ultimately, high-grade HE was successfully treated by a reduction stent and the patient subsequently underwent successful liver transplantation.
- Find related publications in this database (using NLM MeSH Indexing)
- Aged -
- Ammonia - blood
- Dipeptides - administration and dosage
- Hepatic Encephalopathy - drug therapy Hepatic Encephalopathy - etiology
- Humans -
- Liver Diseases, Alcoholic - surgery
- Liver Transplantation -
- Male -
- Portasystemic Shunt, Transjugular Intrahepatic -
- Postoperative Complications -
- Stents -
- Find related publications in this database (Keywords)
- hepatic encephalopathy
- venous ammonia levels
- transjugular intrahepatic portosystemic shunt
- L-ornithine-L-aspartate
- stent reduction